| Description | Linvoseltamab, a bispecific antibody, targets both BCMA (TNFRSF17) and CD3 epsilon, demonstrating a favorable safety profile and promising efficacy in relapsed/refractory multiple myeloma (RRMM) [1][2]. |
| Synonyms | REGN5458 |
| molecular weight | N/A |
| CAS | 2408319-25-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |